Background Analysis: US FDA Advisory Committee to Review Luxturna, a Gene Therapy Proposed by Spark Therapeutics to Treat a Rare Pediatric Vision Disease Report
Background Analysis: US FDA Advisory Committee to Review Luxturna, a Gene Therapy Proposed by Spark Therapeutics to Treat a Rare Pediatric Vision Disease Report